Latest News

The stock's valuation isn't all that high given its growth and dominance in the streaming industry.

The Coach and Kate Spade parent fell after issuing disappointing guidance for the new fiscal year.

Luxury apparel maker beats expectations, raises full-year guidance.

The Vanguard Information Technology ETF has more than doubled the gains of the S&P 500 thus far in 2026.

Active management and concentrated bets drove a 42% one-year return, though the lower-cost Invesco alternative offers broader diversification across 60 healthcare stocks.

Fermi celebrated new customers and financing in Q2. Investors focused on the missing revenue instead.

Caswell discusses $1.28B revenue and AI pipeline penetration amid VA incentive suspension.

The chipmaker has big plans for its growing cash pile.

Target remains solid for the long term, but it could become the victim of elevated expectations on earnings day.

Asian market halts and currency-driven sell-offs can drag down NVIDIA, Micron, Advantest, Arm, and IBM despite steady AI and semiconductor demand, creating potential valuation opportunities.

SUNS merges with Southern Realty Trust to boost scale and cut operating costs.

Payment spend surged past $6 billion as marketplace revenue climbed 6%.

XDEMVY sales hit $173.9M with 69% growth as Tarsus expands into retinal diseases.

This green energy play will profit from the AI boom.

SpaceX and MP Materials offer different ways to invest in future technology infrastructure.

The space stock's post-earnings pullback isn't too meaningful.

The stock continues to look unstoppable.

Record backlog and margin expansion signal strong aerospace and defense demand.

A long-term holding plan can help investors stay strong during gut-wrenching pullbacks.

Managing workplace refreshments can become surprisingly expensive when companies rely on manual processes, inconsistent inventory tracking, excessive food

Data center demand and pipeline expansion drive $21.3M net income surge.

Revenue beat forecasts at $215.2 million as power and memory markets show recovery signs.

POET Technologies shares are rising Thursday after reporting upbeat second-quarter results and disclosing new optical chip orders.

Gene therapy developer advances three Phase III programs toward 2028 regulatory filings.

Adjusted EBITDA surged 115% sequentially as wealth platform launches commercially.